Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome

European Journal of Endocrinology

Volumn 173, Issue 6, 2015, Pages 765-775

  Santos, Alicia ^a   Resmini, Eugenia ^a   Gómez Ansón, Beatriz ^b   Crespo, Iris ^a   Granell, Esther ^b   Valassi, Elena ^a   Pires, Patricia ^c   Vives Gilabert, Yolanda ^c   Martínez Momblán, M Antonia ^a,b   De Juan, Manuel ^b   Mataró, Maria ^d   Webb, Susan M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FRAMINGHAM RISK SCORE; GRAY MATTER; HUMAN; HYPERTENSION; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SCHELTENS SCALE; SYSTOLIC BLOOD PRESSURE; WHITE MATTER LESION; ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; BLOOD; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COGNITIVE DEFECT; DIABETES MELLITUS; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; SMOKING; WHITE MATTER;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADULT; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COGNITION; COGNITION DISORDERS; CUSHING SYNDROME; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; REMISSION INDUCTION; RISK FACTORS; SMOKING; WHITE MATTER;

EID: 84947998658     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0600     Document Type: Article

References (66)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB et al. Diagnosis and complications of Cushing's syndrome: a Consensus Statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
2. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc. 2008-0125)
3. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM & Romijn JA. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2010 95 2699-2714. (doi:10.1210/jc. 2009-2032)
4. Tiemensma J, Biermasz NR, Middlekoop HA, van der Masr RC, Romijn JA & Pereira AM. Increased prevalence of psychopathology and maladaptative personality traits after long-term cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2010 95 E129-E141. (doi:10.1210/jc.2010-0512)
5. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW & Romijn JA. Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2005 90 3279-3286. (doi:10.1210/jc.2004-1375)
6. Lindsay JR, Nansel T, Baid S, Gumowski J & Nieman LK. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. Journal of Clinical Endocrinology and Metabolism 2005 91 447-453. (doi:10.1210/jc.2005-1058)
7. Arnaldi G & Boscaro M. New treatment guidelines on Cushing's disease. F1000 Medicine Reports 2009 1 64. (doi:10.3410/M1-64)
8. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2008 93 2454-2462. (doi:10.1210/jc.2007-2734)
9. Joëls M, Karst H, Krugers HJ & Lucassen PJ. Chronic stress: implications for neuronal morphology, function and neurogenesis. Frontiers in Neuroendocrinology 2007 28 72-96. (doi:10.1016/j.yfrne.2007.04.001)
10. Forget H, Lacroix A, Somma M & Cohen H. Cognitive decline in patients with Cushing's syndrome. Journal of the International Neuropsychological Society 2000 6 20-29. (doi:10.1017/S13556177 00611037)
11. Santos A, Resmini E, Crespo I, Pires P, Vives-Gilabert Y, Granell E, Valassi E, Gómez-Ansón B, Martínez Momblán MA, Mataró M et al. Small cerebellar cortex volume in patients with active Cushing's syndrome. European Journal of Endocrinology 2014 171 461-469. (doi:10.1530/EJE-14-0371)
12. Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H & Lacroix A. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 2005 34 357-369. (doi:10.1016/j.ecl.2005.01.016)
13. Starkman MN, Gebarski SS, Berent S & Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biological Psychiatry 1992 32 756-765. (doi:10.1016/0006-3223(92)90079-F)
14. Resmini E, Santos A, Gómez-Anson B, Vives Y, Pires P, Crespo I, Portella MJ, de Juan-Delago M, Barahona MJ & Webb SM. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. Journal of Clinical Endocrinology 2012 97 663-671. (doi:10.1210/jc.2011-2231)
15. Andela CD, van Haalen FM, Ragnarsson O, Papakokkinou E, Johannson G, Santos A, Webb SM, Biermasz NR, van der Wee NJ, Pereira AM et al. Mechanisms in Endocrinology: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic studies. European Journal of Endocrinology 2015 173 R1-R14. (doi:10.1530/EJE-14-1101)
16. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R & Nappi G. Memory impairment in Cushing's disease. Acta Neurologica Scandinavica 1993 87 52-55. (doi:10.1111/j.1600-0404.1993.tb04075.x)
17. Crespo I, Granell-Moreno E, Santos A, Valassi E, De Juan-Delago M, Vives-Gilabert Y, Webb SM, Gómez-Ansón B & Resmini E. Impaired decision-making process and thinner prefrontal cortex in patients with Cushing's syndrome. Clinical Endocrinology 2014 81 826-833. (doi:10. 1111/cen.12564)
18. Ragnarsson O, Berglund P, Eder DN & Johannsson G. Long-Term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission. Journal of Clinical Endocrinology and Metabolism 2012 97 1640-1648. (doi:10.1210/jc.2012-1945)
19. Andela CD, van der Werff SJ, Pannekoek JN, van den Berg SM, Meijer OC, van Buchem MA, Rombousts SA, van der Mast RC, Romijn JA, Tiemensma J et al. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study. European Journal of Endocrinology 2013 169 811-819. (doi:10.1530/EJE-13-0471)
20. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M & Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism 1999 84 2664-2672. (doi:10.1210/jcem.84.8.5896)
21. Barahona MJ, Sucunza N, Resmini E, Fernández-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J & Webb SM. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2009 94 3365-3371. (doi:10.1210/jc.2009-0766)
22. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 42 2672-2713. (doi:10.1161/STR.0b013e3182299496)
23. Debette S & Markus HS. The clinical importance of white matter hyperintesities on brain magnetic resonance imaging: systematic review and meta-analysis. British Medical Journal 2010 331 c3666. (doi:10.1136/bmj.c3666)
24. Black S, Gao F & Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 2009 40 S48-S52. (doi:10.1161/STROKEAHA.108.537704)
25. Mataró M, Soriano-Raya JJ, López-Oróliz J, Miralbell J & Dacosta-Aguayo R. Cerebrovascular markers in lowered cognitive function. British Medical Journal 2014 42 (Suppl 4) S383-S391.
26. Verdelho A, Madureira S, Ferro JM, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L et al. LADIS study differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. Journal of Neurology, Neurosurgery, and Psychiatry 2007 78 1325-1330. (doi:10.1136/jnnp.2006.110361)
27. Xiong YY & Mok V. Age-related white matter changes. Journal of Aging Research 2011 2011 617927. (doi:10.4061/2011/617927)
28. van der Werff SJ, Andela CD, Nienke Pannekoek J, Meijer OC, van Buchem MA, Rombouts SA, van der Mast RC, Biermasz NR, Pereira AM & van der Wee AJ. Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease. NeuroImage. Clinical 2014 4 659-667. (doi:10.1016/j.nicl.2014.01.017)
29. Pires P, Santos A, Vives-Gilabert Y, Webb SM, Sainz-Ruiz A, Resmini E, Crespo I, de Juan-Delago M & Gómez-Anson B. White matter alterations in the brain of patients with active, remitted and cured Cushing's syndrome: A DTI study. AJNR. American Journal of Neuroradiology 2015 36 1043-1048. (doi:10.3174/ajnr.A4322)
30. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971 9 97-113. (doi:10.1016/0028-3932(71)90067-4)
31. Rey A. L'examin Clinique en Psychologie. Paris: Presses Universitaires de France, 1958.
32. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Archives de Psychologie 1941 28 286-340.
33. Wechsler D. WAIS-III, Wechsler Adult Intelligence Scale-Third Edition. Administration and Scoring Manual. San Antonio, TX, USA: The Psychological Corporation, 2001.
34. Conner's CK. Conner's Continuous Performance Test II, Version 5 for Windows (CPT II): Technical Guide and Software Manual. North Tonawanda, NY: Multi-Health Systems, 2008.
35. Reitan R. Trail making test: Manual for administration, scoring, and interpretation. Bloomington: Indiana University, 1956.
36. Benton AL, Hamsher Kd. Multilingual Aphasia Examination. Iowa City: University of Iowa, 1976.
37. Goodglass H, Kaplan E, Barresi B. Boston diagnostic aphasia examination set, 3/E. Philadelphia: Lippincott Williams & Wilkins, 2001.
38. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin Card Sorting Test-64 Card Version. Professional Manual. Lutz, FL: Psychological Assessment Resources, 2000.
39. Smith A. Symbol Digit Modalities Test. Los Angeles, California: Western Psychological Services, 1973.
40. Lafayette Instrument Company. Grooved Pegboard: Model 32025; User's Manual. Lafayette: Lafayette Instrument Company, 2003.
41. Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment. 5th edn, New York: Oxford University Press, 2012.
42. Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests, administration, norms and commentary. 3rd edn. NewYork: Oxford University Press, 2006.
43. Scheltens P, Barkhof F, Leys D, Pruvo JP, Naura JJ, Vermersch P, Steinling M & Valk J. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. Journal of the Neurological Sciences 1993 114 7-12. (doi:10.1016/0022-510X(93)90041-V)
44. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM & Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008 117 743-753. (doi:10.1161/CIRCULATIONAHA.107.699579)
45. Knopman DS, Mosley TH, Catellier DJ, Sharrett AR & Atherosclerosis Risk in Communities (ARIC) Study. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 2005 65 876-881. (doi:10.1212/01.wnl.0000176074.09733.a8)
46. Longstreth WT, Arnold AM, Manolio TA, Burke GL, Bryan N, Jungreis CA, O'Leary D, Enright PL & Fried L. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology 2000 19 30-42. (doi:10.1159/000026235)
47. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, D'Agostino RB & DeCarli C. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004 63 1591-1599. (doi:10. 1212/01.WNL.0000142968.22691.70)
48. Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA & Au R. Midlife cardiovascular risk impacts executive function: Framingham offspring study. Alzheimer Disease and Associated Disorders 2014 28 16-22. (doi:10.1097/WAD.0b013e3182a715bc)
49. Yaffe K, Vittinghoff E, Pletcher MJ, Hoang TD, Launer LJ, Whitmer R, Coker LH & Sidney S. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation 2014 129 1560-1567. (doi:10.1161/CIRCULATIONAHA.113.004798)
50. Soureti A, Hurling R, Murray P, van Mechelen W & Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. European Journal of Cardiovascular Prevention and Rehabilitation 2010 17 519-523. (doi:10.1097/HJR. 0b013e328337ccd3)
51. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S et al. 2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology 2013 29 151-167. (doi:10.1016/j.cjca.2012.11.032)
52. Michaud K, Forget H & Cohen H. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain and Cognition 2009 71 1-8. (doi:10.1016/j.bandc.2009.02.013)
53. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D & Fried L. Clinical correlates of white matter findings on cranial magnetic imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996 27 1274-1282. (doi:10.1161/01.STR.27.8.1274)
54. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J et al. Age, hypertension and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovascular Diseases 2006 21 315-322. (doi:10.1159/000091536)
55. Shimada K, Kawamoto A, Matsubayashi K & Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990 16 692-699. (doi:10.1161/01. HYP.16.6.692)
56. Liao D, Cooper L, Cai J, Toole JF, Bryan N, Hutchinson RG & Tyroler HA. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control. The ARIC Study. Stroke 1996 27 2262-2270. (doi:10.1161/01.STR.27.12.2262)
57. De Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J & Breteler MM. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002 125 765-772. (doi:10.1093/brain/125.4.765)
58. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A & Ikram MA. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013 61 1354-1359. (doi:10.1161/HYPERTENSIONAHA.111.00430)
59. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA & DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011 77 461-468. (doi:10.1212/WNL.0b013e318227b227)
60. Whelan TB, Schteingart DE, Starkman MN & Smith A. Neuropsychological deficits in Cushing's syndrome. Journal of Nervous and Mental Disease 1980 168 753-757. (doi:10.1097/00005053-198012000-00008)
61. Appelman AP, Exalto LG, van der Graaf Y, Biessels GJ, Mali WP & Geerlings MI. White matter lesions and brain atrophy: more than shared risk factors? A systemiatic review Cerebrovascular Diseases 2009 28 227-242. (doi:10.1159/000226774)
62. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 352 1347-1351. (doi:10.1016/S0140-6736(98)03086-4)
63. Levi Marpillat N, Macquin-Mavier I, Tropeano AI, Bachoud-Levi AC & Maison P. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. Journal of Hypertension 2013 31 1073-1082. (doi:10.1097/HJH.0b013e3283603f53)
64. Johnson AG. NSAIDs and increased blood pressure. What is the clinical significance? Drug Safety 1997 17 277-289. (doi:10.2165/00002018-199717050-00001)
65. Kalafutova S, Juraskova B & Vlcek J. The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure. Advances in Clinical and Experimental Medicine 2014 23 993-1000. (doi:10.17219/acem/37357)
66. Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA, Lambert GW, Scoggins B & Whitworth JA. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 1989 13 416-421. (doi:10.1161/01.HYP.13.5.416)